Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ENDRA Life Sciences Inc NDRA

Healthcare Medical Devices
ENDRA Life Sciences Inc. is developing an enhanced ultrasound technology platform - Thermo Acoustic Enhanced Ultrasound (TAEUS), a technology which characterizes tissue similar to a magnetic resonance imaging (MRI). The Company's TAEUS technology uses radio frequency (RF) pulses to stimulate tissues, using a small fraction (less than 1%) of the amount of energy that would be transmitted into... see more

Recent & Breaking News (NDAQ:NDRA)

ENDRA Life Sciences Achieves Key Quality Management System Certification

Business Wire March 31, 2022

ENDRA Life Sciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

Business Wire March 30, 2022

ENDRA Life Sciences Strengthens TAEUS® System Global Intellectual Property Protection with Issuance of 10th and 11th Chinese Patents

Business Wire March 30, 2022

ENDRA Life Sciences to Report Fourth Quarter 2021 Financial Results on March 30, 2022

Business Wire March 22, 2022

ENDRA Life Sciences to Participate in Two March Investor Conferences

Business Wire March 9, 2022

ENDRA Life Sciences Strengthens TAEUS® System Intellectual Property with Issuance of 24th U.S. Patent

Business Wire March 8, 2022

The Stock Day Podcast Hosted ENDRA Life Sciences Inc. to Discuss the Potential of its Thermo Acoustic Enhanced UltraSound (TAEUS(R))

Newsfile February 15, 2022

ENDRA Life Sciences Strengthens TAEUS® System Global Intellectual Property Portfolio with Issuance of 6th and 7th European Patents

Business Wire February 11, 2022

ENDRA Life Sciences Provides Update on U.S. Regulatory Strategy for its TAEUS® System

Business Wire February 9, 2022

ENDRA Life Sciences Expands into China with Shanghai General Hospital Partnership

Business Wire January 24, 2022

ENDRA Life Sciences to Present at the H.C. Wainwright BioConnect Virtual Conference

Business Wire January 5, 2022

ENDRA Life Sciences Announces New Clinical Study Partnership with King's College Hospital, London

Business Wire December 13, 2021

ENDRA Life Sciences Expands Pharmaceutical Partnerships with VGI Health Technology to Provide TAEUS for Patient Screening and Biomarker Measurement for Phase 2 Study

Business Wire November 29, 2021

ENDRA Life Sciences Further Strengthens TAEUS® System Intellectual Property with Issuance of 22nd and 23rd U.S. Patents

Business Wire November 16, 2021

ENDRA Life Sciences Reports Third Quarter 2021 Financial Results and Provides Business Update

Business Wire November 15, 2021

ENDRA Life Sciences to Report Third Quarter 2021 Financial Results on November 15, 2021

Business Wire November 8, 2021

ENDRA Life Sciences Further Strengthens TAEUS® System Intellectual Property Protection with Issuance of 21st U.S. Patent

Business Wire October 13, 2021

ENDRA Life Sciences to Participate in the H.C. Wainwright 5th Annual NASH Investor Conference

Business Wire October 5, 2021

ENDRA Life Sciences to Participate in Two Upcoming Investment Conferences

Accesswire September 7, 2021

ENDRA Life Sciences Reports Second Quarter 2021 Financial Results and Provides Business Update

Accesswire August 12, 2021